Nanjing RegeneCore Biotech Co.,Ltd is established in the Biomedical Valley of National Nanjing Jiangbei New Area, with a research and office base of nearly 4000 square meters. It is one of the first research and development institutions in the field of nanobodies in China. The company's international scientific consulting expert team has rich experience in the research and development of cell therapy products and clinical applications, providing strong guarantees for the precise positioning and success rate of research and development products. The company has mature and leading nanobody screening technology, and conducts in-depth development in multiple application fields based on this technology.